West Pharmaceutical Services, Inc. (WST) NYSE
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 19.89B |
| Enterprise Value | 19.52B |
| P/E Ratio | 45.99 |
| PEG Ratio | 1.43 |
| Price/Sales Ratio | 8.46 |
| Price/Book Ratio | 9.78 |
| Enterprise/Revenue | 8.41 |
| Enterprise/EBITDA | 29.56 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.19 |
| Operating Margin | 0.23 |
| Return On Assets | 0.16 |
| Return On Equity | 0.21 |
| Revenue | 3.07B |
| Revenue/Share | 48.25 |
| Gross Profit | 1.1B |
| EBITDA | 770.6M |
| Net Income | 493.7M |
| Diluted EPS | 6.8 |
| Total Cash | 464.1M |
| Total Cash/Share | 6.59 |
| Total Debt | 305M |
| Total Debt/Equity | 0.1 |
| Current Ratio | 2.82 |
| Book Value Per Share | 42.16 |
| 52-Week Change | 48.71 |
| 52-Week High | 438.27 |
| 52-Week Low | 223.83 |
| Moving Average 50 Days | 375.84 |
| Moving Average 200 Days | 318.73 |
| Average Volume | 608,103 |
| Shares Outstanding | 69.66M |
| % Held by Institutions | 98.71 |
| Trailing Annual Dividend Rate | 0.92 |
| Trailing Annual Dividend Yield | 0.22 |
| Payout Ratio | 0.1 |
| Last Split Factor | 2:1 |
| Last Split Date | September 27, 2013 |